Tenure Track positions in Bioinformatics/Big Data for Health/AI - AC0221
The LIH is looking for highly motivated outstanding candidates with a strong interest in high dimensional health- or biology- related data analysis to establish a research team and run a dedicated service platform in relevant fields of interest. The focus of the core facility will be to support the current research demand of all LIH departments which are active in the field of cancer, immunologic diseases, and digital and precision public health. Candidates should have a strong background in at least one of the following fields: Bioinformatics, Omics-data analysis, NGS, Tumour Genomics, Artificial Intelligence, System Biology (e.g:Image based system biology), single cell technologies (e.g.: transcriptomicsand proteomics), Big Data for health and programming. Overall, candidates should be able to demonstrate knowledge with Algorithmic, Mathematical, Ontological and Statistical concepts with medical research applications. The applicants should be driven to take a leading role in expanding the research activities at LIH including supervision of Postdocs and PhD students and the acquisition of external funding for novel and innovative research collaborations. Candidates at all career level are invited to apply. Actual positions will be adapted to candidate profile.
Internship in Nutrition & Health (Master students) - TBLM0221
To be part of a joint research project of the “Nutrition & Health Research Group” (Group Leader: Dr. Torsten Bohn) and the “Physical Activity, Sport and Health Group” (Group Leader: Dr. Laurent Malisoux) within the Department of Population Health at the LIH, we are currently looking for a Master student in Nutrition & Health.
Training the next generation of translational scientists
On February 1st, the new i2TRON (Integrating immune strategies for Translational Research in Oncology and Neurology) research and training programme for PhD candidates officially started. Its overarching goal is to develop the ability of doctoral candidates to successfully translate fundamental research findings into innovative pre-clinical and clinical applications, thereby contributing to shaping the next generation of translational researchers and to developing advanced medicine and care.
Targeted proteomics for personalised medicine at LIH
The field of proteomics, i.e. the characterisation of the complete pool of proteins produced by a cell, is acquiring increasing importance in understanding the onset of various diseases and devising new personalised treatments. At LIH, this area is being explored by Prof Gunnar Dittmar and his team at the Proteomics of Cellular Signaling research group of the Quantitative Biology Unit (QBU). His work has resulted in the publication of his 100th scientific paper in the January 2021 issue of the prestigious international journal “Analytical Chemistry”. In this interview, Prof Dittmar discusses his expertise and research focus.
Can the “dark side” of the genome help fight cardiovascular disease?
Understanding whether specific types of RNA molecules can provide insight into the development of cardiovascular diseases is “at the heart” of the research performed by the EU-funded CardioRNA project partners. Through a recently released educational video, the consortium explains its activities and goals.
Characterising cardiometabolic health through inflammation and micronutrients
Researchers from the LIH Department of Population Health (DoPH) recently investigated whether the concentration of micronutrients/secondary plant compounds, markers of oxidative stress/inflammation, as well as socioeconomic indicators can be associated with the risk of metabolic syndrome (MetS). Their study, which was published in the January 2021 issue of the international journal Nutrients, is part of the FNR-funded CORE project “Micronutrients, Pollutants and Cardiometabolic Health in Luxembourg” (IMPACT.lu). IMPACT.lu builds on data from the European Health Examination Survey in Luxembourg (EHES-LUX), a population-based survey conducted between February 2013 and January 2015 in the Grand Duchy. In this interview, Dr. Maria Ruiz-Castell, Scientist within the Public Health Research Unit and leader of IMPACT-LUX and EHES-LUX, and Dr. Torsten Bohn, Group Leader of the Nutrition and Health Research Group, share their findings.
21 January 2021 11:00 AM
WEBINAR: Lecture series Infection & Immunity: "Antigen-speciﬁc CD4 T cell responses in humans: SARS-CoV-2 and beyond"- Prof Alexander Scheffold
2020 - A full and rewarding year
The year 2020, despite its challenges, brought about a string of successes for the institute and its staff. From the cross-departmental efforts in setting up and coordinating flagship COVID-19 projects, to the Department of Infection and Immunity’s (DII) advances in the fields of autoimmunity and pain relief, to the Department of Oncology’s (DONC) breakthroughs in cancer immunotherapy and characterisation, through to the Department of Population Health’s (DoPH) findings in terms of public health, this year has been one to remember.
Télévie researchers go “back to the lab”!
On January 13, the « Rentrée des chercheurs » took place in the form of a series of video clips. This event promoted by Télévie symbolically marks the start of the new research projects funded by the charitable organisation and by the Belgian « Fonds National de la Recherche Scientifique » (FNRS). As one of the scientists supported by Télévie, Dr Bassam Janji, Group leader of the Tumor Immunotherapy and Microenvironment (TIME) at the Department of Oncology of the Luxembourg Institute of Health, was featured in this original initiative, which provided the opportunity to discuss the work of his research group.